HomeInsightsStock Comparison

Fdc Ltd vs Syncom Formulations India Ltd Stock Comparison

Fdc Ltd vs Syncom Formulations India Ltd Stock Comparison

Last Updated on: Jul 07, 2025

Key Highlights

  • The Latest Trading Price of FDC Ltd is ₹ 507.75 as of 07 Jul 11:32.
  • The P/E Ratio of FDC Ltd changed from 20 on March 2022 to 16 on March 2021 . This represents a CAGR of -4.36% over 5 yearsThe P/E Ratio of Syncom Formulations (India) Ltd changed from 46.2 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of FDC Ltd changed from ₹ 4336 crore on March 2022 to ₹ 4822 crore on March 2021 . This represents a CAGR of 2.15% over 5 yearsThe Market Cap of Syncom Formulations (India) Ltd changed from ₹ 916.79 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 years.
  • The revenue of FDC Ltd for the Mar '25 is ₹ 507.97 crore as compare to the Dec '24 revenue of ₹ 482.94 crore. This represent the growth of 5.18% The revenue of Syncom Formulations (India) Ltd for the Mar '25 is ₹ 155.83 crore as compare to the Dec '24 revenue of ₹ 131.57 crore. This represent the growth of 18.44%.
  • The ebitda of FDC Ltd for the Mar '25 is ₹ 70.06 crore as compare to the Dec '24 ebitda of ₹ 65.48 crore. This represent the growth of 6.99% The ebitda of Syncom Formulations (India) Ltd for the Mar '25 is ₹ 24.7 crore as compare to the Dec '24 ebitda of ₹ 18.77 crore. This represent the growth of 31.59%.
  • The net profit of FDC Ltd changed from ₹ 109.81 crore to ₹ 38.67 crore over 8 quarters. This represents a CAGR of -40.66% The net profit of Syncom Formulations (India) Ltd changed from ₹ 4.4 crore to ₹ 17.69 crore over 8 quarters. This represents a CAGR of 100.51% .
  • The Dividend Payout of FDC Ltd changed from 5.54 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Syncom Formulations (India) Ltd changed from 13.07 % on March 2022 to 0 % on March 2024 . This represents a CAGR of -100.00% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About FDC Ltd

  • FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
  • The Company is a prominent player in the Indian pharmaceutical industry, renowned for its expertise in developing specialised formulations.
  • It leads the market in sectors such as Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies.
  • It has established a global footprint in both domestic and international market, standing as a beacon of excellence in pharmaceutical and consumer healthcare industry. Promoted as a partnership firm in 1936 by the Late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods, FDC Limited was established on September 23, 1940.

About Syncom Formulations (India) Ltd

  • Incorporated as a private limited Company in 1988, Syncom Formulations (India) Limited was converted into a public limited Company in June, 1992.
  • The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency.
  • Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
  • Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations.

FDC Ltd News Hub

News

Volumes jump at FDC Ltd counter

Bajaj Finance Ltd, P I Industries Ltd, Anand Rathi Wealth Ltd, Cipla Ltd are among the oth...

Read more

16 Jun 2025 11:00

News

FDC to conduct board meeting

FDC will hold a meeting of the Board of Directors of the Company on 28 May 2025. Powered b...

Read more

23 May 2025 17:29

News

FDC to declare Quarterly Results

FDC will hold a meeting of the Board of Directors of the Company on 12 February 2025. Powe...

Read more

08 Feb 2025 11:03

News

FDC gets USFDA nod for anti-bacterial drug

The announcement was made at the fag end of market hours yesterday. Cefixime is used to tr...

Read more

19 Dec 2024 10:47

News

Board of FDC recommends first interim dividend

FDC announced that the Board of Directors of the Company at its meeting held on 6 November...

Read more

07 Nov 2024 15:15

News

FDC schedules board meeting

FDC will hold a meeting of the Board of Directors of the Company on 6 November 2024 Powere...

Read more

29 Oct 2024 15:20

Syncom Formulations (India) Ltd News Hub

News

Syncom Formulations (India) schedules board meeting

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

14 May 2025 14:06

News

Syncom Formulations (India) to convene board meeting

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

05 Nov 2024 14:12

News

Syncom Formulations (India) schedules AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 2024 17:48

News

Syncom Formulations (India) to hold AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 2024 10:30

News

Syncom Formulations gains after Q1 PAT rises over 73% YoY

Net sales rose by 45.8% year-over-year (YoY) during the quarter to Rs 87.26 crore. Total e...

Read more

13 Aug 2024 13:37

News

Syncom Formulations (India) announces board meeting date

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

06 Aug 2024 11:37

SWOT Analysis Of FDC Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

SWOT Analysis Of Syncom Formulations (India) Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

BlinkX Score for FDC Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Syncom Formulations (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of FDC Ltd and Syncom Formulations (India) Ltd

Which company has a larger market capitalization, FDC Ltd or Syncom Formulations (India) Ltd?

Market cap of FDC Ltd is 7,965 Cr while Market cap of Syncom Formulations (India) Ltd is 1,811 Cr

What are the key factors driving the stock performance of FDC Ltd and Syncom Formulations (India) Ltd?

The stock performance of FDC Ltd and Syncom Formulations (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for FDC Ltd and Syncom Formulations (India) Ltd?

As of July 7, 2025, the FDC Ltd stock price is INR ₹489.25. On the other hand, Syncom Formulations (India) Ltd stock price is INR ₹19.27.

How do dividend payouts of FDC Ltd and Syncom Formulations (India) Ltd compare?

To compare the dividend payouts of FDC Ltd and Syncom Formulations (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions